Cubist Systematic Strategies’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $598K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $116K | Sell |
|
|||||
|
2024
Q3 | $237K | Sell |
|
|||||
|
2024
Q2 | $588K | Buy |
|
|||||
|
2024
Q1 | $477K | Sell |
|
|||||
|
2023
Q4 | $779K | Buy |
|
|||||
|
2023
Q3 | $766K | Sell |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $1.47M | Buy |
|
|||||
|
2022
Q4 | $1.62M | Sell |
|
|||||
|
2022
Q3 | $2.09M | Buy |
|
|||||
|
2022
Q2 | $1.77M | Buy |
|
|||||
|
2022
Q1 | $299K | Sell |
|
|||||
|
2021
Q4 | $3.5M | Buy |
|
|||||
|
2021
Q3 | $648K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $201K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $655K | Buy |
|
|||||
|
2020
Q2 | $498K | Buy |
|
|||||
|
2020
Q1 | $294K | Sell |
|
|||||
|
2019
Q4 | $496K | Buy |
|
|||||
|
2019
Q3 | $336K | Buy |
|
|||||
|
2019
Q2 | $414K | Buy |
|
|||||
|
2019
Q1 | $356K | Buy |
|
|||||
|
2018
Q4 | $235K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $540K | Sell |
|
|||||
|
2018
Q1 | $473K | Buy |
|
|||||
|
2017
Q4 | $270K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $9K | Buy |
|